A former chief counsel for the US Food and Drug Administration says cannabinoids have put it in a “nearly impossible situation” while the agency’s overall regulatory oversight of the dietary supplement industry lags behind the growth of the market.
Stacy Cline Amin, commenting via email on questions from HBW Insight, also said she expects publication in the “near future”...





